SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 60111.
  • 2
    Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 1997; 24: 10615.
  • 3
    Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995; 38: 27483.
  • 4
    Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. J Rheumatol 1996; 23: 19535.
  • 5
    Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol 1999; 26: 4907.
  • 6
    Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, et al. Randomised clinical trials and longitudinal observation studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol 1999; 26: 5047.
  • 7
    Brooks P, Hochberg M. Outcome measures and classification criteria for the rheumatic diseases: a compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups. Rheumatology (Oxford) 2001; 40: 896906.
  • 8
    Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center; 1994.
  • 9
    Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 10
    Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998; 41: 116172.
  • 11
    Alarcón GS, Friedman AW, Straaton KV, Lisse J, Moulds JM, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 1999; 8: 197209.
  • 12
    Friedman AW, Alarcón GS, McGwin G Jr, Straaton KV, Roseman J, Goel N, et al. Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self-reported functional outcome in a large cohort study. Arthritis Care Res 1999; 12: 25666.
  • 13
    Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87: 23541.
  • 14
    Russo J, Trujillo CA, Wingerson D, Decker K, Ries R, Wetzler H, et al. The MOS 36-item short form health survey: reliability, validity, and preliminary findings in schizophrenic outpatients. Med Care 1998; 36: 7526.
  • 15
    Wittchen HU, Beloch E. The impact of social phobia on quality of life. Int Clin Psychopharmacol 2002; 3: 1523.
  • 16
    Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000; 43: 147887.
  • 17
    Wiles NJ, Scott DG, Barrett EM, Merry P, Arie E, Gaffney K, et al. Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36.in a community and a clinic based sample. Ann Rheum Dis 2001; 60: 95661.
  • 18
    Da Costa D, Dobkin PL, Fitzcharles M-A, Fortin PR, Beaulieu A, Zummer M, et al. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000; 27: 36572.
  • 19
    Sprangers MAG, de Regt EB, Andries F, van Agt HME, Bijl RV, de Boer JB, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 2000; 53: 895907.
  • 20
    Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24: 67589.
  • 21
    Gilboe I-M, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999; 26: 1694700.
  • 22
    Bae S-C, Hashimoto H, Karlson EW, Liang MH, Daltroy LH. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001; 28: 124551.
  • 23
    Sutcliffe N, Clarke AE, Levinton C, Frost C, Gordon C, Isenberg DA. Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 23526.
  • 24
    Dobkin PL, da Costa D, Dritsa M, Fortin PR, Senécal J-L, Goulet J-R, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 1999; 12: 40110.
  • 25
    Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001; 28: 52532.
  • 26
    Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998; 7: 1017.
  • 27
    Alarcón GS, Roseman JM, Bartolucci AA, Friedman AW, Moulds JM, Goel N, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 1998; 41: 117380.
  • 28
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 29
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 16072.
  • 30
    Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 110718.
  • 31
    Liang MH, Fortin PR, Isenberg DA, Snaith L. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda. Rheumatol Int 1991; 11: 1336.
  • 32
    Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 80913.
  • 33
    Cohen S, Mermelstein R, Kamarch T, Hoberman HN. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: theory, research and applications. Boston: Martinus Nijhoff; 1985. p. 7394.
  • 34
    Engle EW, Callahan LF, Pincus T, Hochberg MC. Learned helplessness in systemic lupus erythematosus: analysis using the rheumatology attitudes index. Arthritis Rheum 1990; 33: 2815.
  • 35
    Pilowsky I. Dimensions of illness behavior as measured by the illness behavior questionnaire: a replication study. J Psychosom Res 1993; 37: 5362.
  • 36
    Scott DL, Garrood T. Quality of life measures: use and abuse. Bailliere's Clin Rheumatol 2000; 14: 66387.
  • 37
    Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33: S26479.
  • 38
    Ware JE, Kosinski M, Dewey JE. How to score version two of the SF-36 health survey. Lincoln (RI): Quality Metric; 2000.
  • 39
    Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999; 8: 27986.
  • 40
    Da Costa D, Clarke AE, Dobkin PL, Senecal J-L, Fortin PR, Danoff DS, et al. The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus. Int J Qual Health Care 1999; 11: 2017.
  • 41
    Vu T, Escalante A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol 1999; 26: 2595601.
  • 42
    Gilboe I-M, Kvien TK, Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. J Rheumatol 2001; 28: 26674.
  • 43
    Stoll T, Kauer Y, Buchi S, Klaghofer R, Sensky T, Villiger PM. Prediction of depression in systemic lupus erythematosus patients using SF-36 mental health scores. Rheumatology (Oxford) 2001; 40: 6958.
  • 44
    Dobkin PL, da Costa D, Fortin PR, Edworthy S, Barr S, Esdaile JM, et al. Living with lupus: a prospective Pan-Canadian study. J Rheumatol 2001; 28: 24428.
  • 45
    Schlenk EA, Erlen JA, Dunbar-Jacob J, McDowell J, Engberg S, Sereika SM, et al. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res 1998; 7: 5765.
  • 46
    Dobkin PL, Fortin PR, Joseph L, Esdaile JM, Danoff DS, Clarke AE. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res 1998; 11: 2331.
  • 47
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 4756.
  • 48
    Clarke AE, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al. An international perspective on the well-being and health care costs for patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 150011.
  • 49
    Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. Lack of correlation among the 3 outcomes describing systemic lupus erythematosus: disease activity, damage and quality of life. Clin Exp Rheumatol 1996; 14: 3058.
  • 50
    Gladman D, Urowitz M, Ong A, Gough J, MacKinnon A. A comparison of 5 health status instruments in patients with systemic lupus erythematosus. Lupus 1996; 5: 1905.
  • 51
    Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 160814.
  • 52
    Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24: 21458.
  • 53
    Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996; 23: 141831.
  • 54
    Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000; 29: 208.
  • 55
    Friedman AW, Tew MB, Ahn C, McGwin G Jr, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia. Lupus 2003; 12: 2749.
  • 56
    Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 37981.